Harvard FUSION Symposium

October 17th, 2017 ~ 12:00am–12:00pm ~ (By invitation only)

The Science and Business of Combating Antibiotic Resistance

The second Harvard FUSION symposium of the Blavatnik Biomedical Accelerator and the HBS Blavatnik Fellowship in Life Science Entrepreneurship

By invitation only. Please direct inquiries to .(JavaScript must be enabled to view this email address).


HBS and Blavatnik Biomedical Accelerator logos

FUSION is the annual Harvard University symposium that integrates perspectives from science and business to expand upon the promise of an emerging field.

Featuring a keynote address by
Anthony S. Fauci, MD,
Director of the National Institute of Allergy and Infectious Diseases (NIAID). Dr. Fauci has advised five U.S. presidents and oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established and emerging infectious diseases.

Panel discussions

Science — What can we do to avoid a "post-antibiotic era"? What research strategies are leading in the development of new antimicrobial therapies today? What challenges remain? Addressed by leading scientists from Harvard and beyond.

Business and Policy — How can business models, incentives, or regulatory changes favor the development of new antimicrobial products and services for patients? Discussed by a panel of distinguished life-science business leaders, policy experts, and venture capitalists.

Press Contact

Caroline Perry
(617) 495-4157
Email